US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Stage

0.3754

0.0000

Volume:- -

Turnover:- -

Market Cap:10.85M

PE:-0.11

High:0.3754

Open:0.3754

Low:0.3754

Close:0.3754

52wk High:9.50

52wk Low:0.2700

Shares:28.91M

Float Shares:20.31M

Volume Ratio:- -

T/O Rate:- -

Dividend:0.05

Dividend Rate:13.32%

EPS(TTM):-3.3321

EPS(LYR):-3.1264

ROE:-44.60%

ROA:-3.54%

PB:0.07

PE(LYR):-0.12

Loading ...

Overview Company News Filings

Why Greenland's Pituffik Base Is Center Stage -- WSJ

Netflix's New Stage: Acquisitions, Live Events and Podcasts

$500 Billion Giant CalPERS Bets Big On Early-Stage Companies, Cuts Buyout Exposure

A Look At Edgewise Therapeutics (EWTX) Valuation After Detailed Late Stage Pipeline Milestone Update

Simply Wall St.

DAVOS: American AI Takes Center Stage -- Market Talk

Trump's Presser Set the Stage for a Doozy at Davos -- WSJ

Intuit: Early-Stage Product Cycles and Undervalued Growth Support Path to Doubling Revenue and EPS by FY30

MongoDB: Early-Stage AI Beneficiary With Reaccelerating Atlas Growth and Expanding Database Moat – Buy Rating Affirmed

BioAge Labs: Early-Stage Promise for BGE-102 Balanced by Long Timelines and Clinical Risk, Justifying Hold Rating

Alpha HPA Locks In High-Value Semiconductor and Pharma Deals as Stage 2 Build Advances

BioAge Labs: Early-Stage NLRP3 Opportunity in Ophthalmology and Cardiometabolic Disease Warrants Neutral ‘Hold’ Amid Long Clinical Timelines

Social Security is making a change that could disrupt service for millions of Americans

Lexicon Pharmaceuticals: Global INPEFA Expansion and Late-Stage Pipeline Catalysts Support Buy Rating and $4 Target

Vizsla Silver Fully Funds Panuco as Project Moves From Study Stage to Construction Readiness

Definium Therapeutics: Advancing Late-Stage Psychedelic Pipeline and Diversifying Assets Underpin Buy Rating and $61 Target

Invivyd to Launch Mid-Stage Trial for Investigational Antibody on Long COVID

MT Newswires Live

Reaffirming Axsome Therapeutics as a Buy on Robust Commercial Growth and Advancing Late‑Stage Pipeline, With a Raised $260 Price Target

Amigo Launches Early-Stage Gold Exploration Push in Tanzania

'Approval Is Not Possible At This Stage,' EPP Chief Says, Threatening Collapse Of EU-US Trade Deal: 'Must Be Put On Hold'

Benzinga_recent_news

Health In Tech: Early-Stage Disruptor Poised for High-Growth Expansion, Underpinned by Strong Balance Sheet and Strategic Partnerships

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/SSI/news?page=10"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SSI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"SSI\",,,,,undefined,":{"symbol":"SSI","market":"US","secType":"STK","nameCN":"Stage","latestPrice":0.3754,"timestamp":1588968000000,"preClose":0.3754,"halted":3,"volume":0,"delay":0,"changeRate":0,"floatShares":20307519,"shares":28911336,"eps":-3.332056,"marketStatus":"Halted","change":0,"latestTime":"05-08 16:00:00 EDT","open":0.3754,"high":0.3754,"low":0.3754,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.332056,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1774252800000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":998884800000,"exchange":"NYSE","adjPreClose":0.3754,"dividendRate":0.133191,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"SSI\",,,,,undefined,":{"symbol":"SSI","floatShares":20307519,"roa":"-3.54%","roe":"-44.60%","lyrEps":-3.1264,"shares":28911336,"dividePrice":0.05,"high":0.3754,"amplitude":0,"preClose":0.3754,"low":0.3754,"week52Low":0.27,"pbRate":"0.07","week52High":9.5,"institutionHeld":0.5253,"latestPrice":0.3754,"eps":-3.332056,"divideRate":0.133191,"volume":0,"delay":0,"ttmEps":-3.332056,"open":0.3754,"prevYearClose":8.12},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SSI\",params:#limit:5,,,undefined,":[{"market":"US","date":"2019-11-21","symbol":"SSI","fiscalQuarterEnding":"2019/10","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1574312400000,"reportTimeType":"pre","actualEps":-0.15},{"date":"2019-08-22","symbol":"SSI","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2019/07","expectedEps":null,"defaultRemindTime":1566460800000,"name":null,"time":"Pre-Market","dateTimestamp":1566446400000,"actualEps":-0.6},{"market":"US","date":"2019-05-23","symbol":"SSI","fiscalQuarterEnding":"2019/04","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1558584000000,"reportTimeType":"pre","actualEps":-1.67},{"market":"US","date":"2019-03-07","symbol":"SSI","fiscalQuarterEnding":"2019/01","expectedEps":0.73,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1551934800000,"reportTimeType":"pre","actualEps":0.25},{"market":"US","date":"2018-12-03","symbol":"SSI","amount":0.05,"name":"Stage Stores Inc","currency":"USD","type":"dividend","dateTimestamp":1543813200000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SSI\",market:\"US\",,,undefined,":[{"executeDate":"2017-02-24","recordDate":null,"paymentDate":null,"value":0.15,"currency":"USD"},{"executeDate":"2017-05-25","recordDate":null,"paymentDate":null,"value":0.05,"currency":"USD"},{"executeDate":"2017-08-25","recordDate":null,"paymentDate":null,"value":0.05,"currency":"USD"},{"executeDate":"2017-11-27","recordDate":null,"paymentDate":null,"value":0.05,"currency":"USD"},{"executeDate":"2018-03-05","recordDate":null,"paymentDate":null,"value":0.05,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SSI\",market:\"US\",delay:true,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SSI\",pageSize:20,pageCount:10,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2605436447","title":"Why Greenland's Pituffik Base Is Center Stage -- WSJ","url":"https://stock-news.laohu8.com/highlight/detail?id=2605436447","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605436447?lang=en_us&edition=fundamental","pubTime":"2026-01-22 06:23","pubTimestamp":1769034180,"startTime":"0","endTime":"0","summary":"By Sune Engel Rasmussen, Daniel Michaels and Natalie Andrews. President Trump's statement Wednesday that Greenland is a core national security interest puts a focus on the existing U.S. military presence on the island. At one point, the U.S. maintained 17 bases in Greenland, and kept about 10,000 troops there. Today, there are fewer than 200 forces at one installation, Pituffik Space Base.Formerly known as Thule Air Base, Pituffik was built in 1951. The northernmost U.S. military installation, it is a collection of barracks, hangars, fuel tanks and satellite-dish domes. On a mountain plateau, a massive trapezoid-shaped radar monitors the sky for potential hostile missiles. Behind the base, the vast ice sheet stretches for more than 600,000 square miles. Under a longstanding treaty with Denmark, which controls the island, the U.S. has wide latitude to station troops and expand its number of bases on the island.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SSI"],"gpt_icon":0},{"id":"2605438687","title":"Netflix's New Stage: Acquisitions, Live Events and Podcasts","url":"https://stock-news.laohu8.com/highlight/detail?id=2605438687","media":"Benzinga","labels":["corporation","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605438687?lang=en_us&edition=fundamental","pubTime":"2026-01-22 04:47","pubTimestamp":1769028424,"startTime":"0","endTime":"0","summary":"Netflix Q4 earnings call highlighted the company&#39;s transition to becoming a multi-dimensional entertainment hub.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/large-cap/26/01/50052964/netflixs-new-stage-acquisitions-live-events-and-podcasts","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z9505.USD","IE00BZ1G4Q59.USD","LU0106261372.USD","LU0203202063.USD","LU0082616367.USD","LU0203201768.USD","LU0109391861.USD","LU0868494708.USD","SSI","LU0234572021.USD","BK4527","LU2264538146.SGD","LU2326559502.SGD","WBD","LU1316542783.SGD","LU2552382215.SGD","LU0980610538.SGD","LU0210536198.USD","LU1720051017.SGD","LU1429558221.USD","IE00BQXX3F31.USD","BK4532","LU0127658192.USD","LU1814569148.SGD","LU2461242641.AUD","LU2237957902.USD","LU1035775433.USD","BK4587","LU0320765059.SGD","SGXZ23171101.USD","NFLX","LU0006306889.USD","LU2543165471.USD","LU2087625088.SGD","LU0648001328.SGD","BK4551","LU2237957811.SGD","LU0225283273.USD","LU0719512351.SGD","LU1435385759.SGD","LU0256863811.USD","LU1720051108.HKD","BK4548","LU0097036916.USD","BK4585","LU0256863902.USD","LU0942090050.USD","LU2362541513.USD","LU1201861249.SGD"],"gpt_icon":1},{"id":"2605872334","title":"$500 Billion Giant CalPERS Bets Big On Early-Stage Companies, Cuts Buyout Exposure","url":"https://stock-news.laohu8.com/highlight/detail?id=2605872334","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605872334?lang=en_us&edition=fundamental","pubTime":"2026-01-22 03:09","pubTimestamp":1769022540,"startTime":"0","endTime":"0","summary":"The California Public Employees Retirement System is revamping its private equity portfolio, with venture capital and growth equity.","market":"sh","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/01/21/Severance--Pensions-Shaped-Outcomes.jpeg?optimize=medium&dpr=2&auto=webp&width=260","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/01/21/Severance--Pensions-Shaped-Outcomes.jpeg?optimize=medium&dpr=2&auto=webp&width=260"],"rights":{"source":"benzinga_hot_news","url":"https://www.benzinga.com/news/financing/26/01/50049531/500-billion-giant-calpers-bets-big-on-early-stage-companies-cuts-buyout-exposure","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/financing/26/01/50049531/500-billion-giant-calpers-bets-big-on-early-stage-companies-cuts-buyout-exposure","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_hot_news","symbols":["SSI"],"gpt_icon":0},{"id":"2605435933","title":"A Look At Edgewise Therapeutics (EWTX) Valuation After Detailed Late Stage Pipeline Milestone Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2605435933","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605435933?lang=en_us&edition=fundamental","pubTime":"2026-01-22 02:34","pubTimestamp":1769020445,"startTime":"0","endTime":"0","summary":"Edgewise Therapeutics (EWTX) updated investors on its late stage pipeline, outlining 2026 milestones for muscular dystrophy and cardiovascular programs. These include key sevasemten trial readouts and a potential future New Drug Application submission.\nSee our latest analysis for Edgewise Therapeutics.\nThe update on 2026 clinical milestones comes as Edgewise Therapeutics trades at $28.73, with a 90 day share price return of 92.95% and a 3 year total shareholder return of 160.24%. This...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ewtx/edgewise-therapeutics/news/a-look-at-edgewise-therapeutics-ewtx-valuation-after-detaile-1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ewtx/edgewise-therapeutics/news/a-look-at-edgewise-therapeutics-ewtx-valuation-after-detaile-1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["SSI","BK4007","EWTX","BK4539"],"gpt_icon":0},{"id":"2605484435","title":"DAVOS: American AI Takes Center Stage -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2605484435","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605484435?lang=en_us&edition=fundamental","pubTime":"2026-01-22 01:42","pubTimestamp":1769017320,"startTime":"0","endTime":"0","summary":"1242 ET - American AI businesses remain a focus at Davos even as attendees huddle over escalating U.S.-Europe tensions, Wedbush analysts write in a note. Despite geopolitical worries, \"the one thing that is clear from Davos is the US tech world is dominating the AI Revolution with China a distant second,\" they write. After conversations with tech executives in Davos, the analysts write that investors are both excited about the U.S.' AI lead and jittery about the capital spending needing to get there. \"We believe both sides can be right at the same time,\" they write, adding that they expect to see tech firms doubling down on AI capital spending as 4Q results come in. ","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4551","BK4588","AI","BK4117","BK4528","BK4543","SSI","BK4023","AFG","BK4107","BK4587"],"gpt_icon":0},{"id":"2605110116","title":"Trump's Presser Set the Stage for a Doozy at Davos -- WSJ","url":"https://stock-news.laohu8.com/highlight/detail?id=2605110116","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605110116?lang=en_us&edition=fundamental","pubTime":"2026-01-21 20:05","pubTimestamp":1768997100,"startTime":"0","endTime":"0","summary":"World leaders are no longer just on edge from President Trump's \"keep 'em guessing\" foreign policy. Now, they are publicly starting to bristle and forge new alliances. Trump's threats to allies are stirring worries that the U.S. has lost its way, and European and Canadian leaders are openly discussing what was once unthinkable -- a \"decoupling\" of Europe and Canada from the U.S.The latest showdown is over Trump's intensifying pursuit of Greenland, which has prompted Europeans to draw a line in the snow.Davos is gearing up for Trump's arrival. Tensions are simmering over his designs on Greenland. His trip was briefly delayed by a \"minor electrical issue\" on Air Force One, which returned to Joint Base Andrews less than an hour after departing. Ahead of his arrival, Treasury Secretary Scott Bessent told European allies not to stand in the way of the U.S.'s national-security goals and said Denmark is irrelevant. Follow live updates.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SSI"],"gpt_icon":0},{"id":"2605106179","title":"Intuit: Early-Stage Product Cycles and Undervalued Growth Support Path to Doubling Revenue and EPS by FY30","url":"https://stock-news.laohu8.com/highlight/detail?id=2605106179","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605106179?lang=en_us&edition=fundamental","pubTime":"2026-01-21 19:15","pubTimestamp":1768994137,"startTime":"0","endTime":"0","summary":"Keith Weiss, an analyst from Morgan Stanley, maintained the Buy rating on Intuit. The associated price target remains the same with $880.00. Keith ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/intuit-early-stage-product-cycles-and-undervalued-growth-support-path-to-doubling-revenue-and-eps-by-fy30-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/intuit-early-stage-product-cycles-and-undervalued-growth-support-path-to-doubling-revenue-and-eps-by-fy30-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SSI","INTU"],"gpt_icon":0},{"id":"2605103888","title":"MongoDB: Early-Stage AI Beneficiary With Reaccelerating Atlas Growth and Expanding Database Moat – Buy Rating Affirmed","url":"https://stock-news.laohu8.com/highlight/detail?id=2605103888","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605103888?lang=en_us&edition=fundamental","pubTime":"2026-01-21 18:15","pubTimestamp":1768990536,"startTime":"0","endTime":"0","summary":"William Blair analyst Jason Ader has maintained their bullish stance on MDB stock, giving a Buy rating yesterday. Jason Ader has given his Buy rati...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/mongodb-early-stage-ai-beneficiary-with-reaccelerating-atlas-growth-and-expanding-database-moat-buy-rating-affirmed-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/mongodb-early-stage-ai-beneficiary-with-reaccelerating-atlas-growth-and-expanding-database-moat-buy-rating-affirmed-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SSI","AFH"],"gpt_icon":0},{"id":"2605934140","title":"BioAge Labs: Early-Stage Promise for BGE-102 Balanced by Long Timelines and Clinical Risk, Justifying Hold Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2605934140","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605934140?lang=en_us&edition=fundamental","pubTime":"2026-01-21 07:56","pubTimestamp":1768953391,"startTime":"0","endTime":"0","summary":"Analyst Michael Ulz from Morgan Stanley maintained a Hold rating on BioAge Labs, Inc. and keeping the price target at $12.00. Michael Ulz has given...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/bioage-labs-early-stage-promise-for-bge-102-balanced-by-long-timelines-and-clinical-risk-justifying-hold-rating-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/bioage-labs-early-stage-promise-for-bge-102-balanced-by-long-timelines-and-clinical-risk-justifying-hold-rating-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BIOA","SSI"],"gpt_icon":0},{"id":"2605357140","title":"Alpha HPA Locks In High-Value Semiconductor and Pharma Deals as Stage 2 Build Advances","url":"https://stock-news.laohu8.com/highlight/detail?id=2605357140","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605357140?lang=en_us&edition=fundamental","pubTime":"2026-01-21 07:30","pubTimestamp":1768951853,"startTime":"0","endTime":"0","summary":"Alpha HPA Limited ( ($AU:A4N) ) has issued an announcement. Alpha HPA has reported strong momentum in securing high-value demand across semiconduct...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/alpha-hpa-locks-in-high-value-semiconductor-and-pharma-deals-as-stage-2-build-advances?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/alpha-hpa-locks-in-high-value-semiconductor-and-pharma-deals-as-stage-2-build-advances?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SSI","BGSX"],"gpt_icon":0},{"id":"2605145355","title":"BioAge Labs: Early-Stage NLRP3 Opportunity in Ophthalmology and Cardiometabolic Disease Warrants Neutral ‘Hold’ Amid Long Clinical Timelines","url":"https://stock-news.laohu8.com/highlight/detail?id=2605145355","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605145355?lang=en_us&edition=fundamental","pubTime":"2026-01-21 02:55","pubTimestamp":1768935350,"startTime":"0","endTime":"0","summary":"William Blair analyst Andy Hsieh has reiterated their neutral stance on BIOA stock, giving a Hold rating yesterday. Andy Hsieh has given his Hold r...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/bioage-labs-early-stage-nlrp3-opportunity-in-ophthalmology-and-cardiometabolic-disease-warrants-neutral-hold-amid-long-clinical-timelines-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/bioage-labs-early-stage-nlrp3-opportunity-in-ophthalmology-and-cardiometabolic-disease-warrants-neutral-hold-amid-long-clinical-timelines-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BIOA","SSI"],"gpt_icon":0},{"id":"2605148710","title":"Social Security is making a change that could disrupt service for millions of Americans","url":"https://stock-news.laohu8.com/highlight/detail?id=2605148710","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605148710?lang=en_us&edition=fundamental","pubTime":"2026-01-21 02:02","pubTimestamp":1768932120,"startTime":"0","endTime":"0","summary":"A slimmed-down workforce will handle cases on a nationwide basis - what does that mean for its 75 million beneficiaries?The Social Security Administration has more than 1,200 local field offices.Social Security Administration will overhaul its workflow to accommodate a slimmed-down workforce and handle its cases on a nationwide basis - as opposed to addressing beneficiaries' cases locally. That could lead to further service disruptions at an agency that handles benefits for about 75 million Americans.The change, which will come in about two months, could lead to delays in service as employees are forced to learn the nuances of different state laws that could impact benefits. Rather than working as regional silos, each of the 1,200 local field offices will soon manage benefits nationally.However, the changes being made \"will empower field office staff to focus on what they do best, resolving customers' needs in-person with care, accuracy, and efficiency, while directing more complex cas","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","SSI","NASC"],"gpt_icon":0},{"id":"2605117177","title":"Lexicon Pharmaceuticals: Global INPEFA Expansion and Late-Stage Pipeline Catalysts Support Buy Rating and $4 Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2605117177","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605117177?lang=en_us&edition=fundamental","pubTime":"2026-01-21 00:16","pubTimestamp":1768925794,"startTime":"0","endTime":"0","summary":"In a report released today, Joseph Pantginis from H.C. Wainwright maintained a Buy rating on Lexicon Pharmaceuticals, with a price target of $4.00....","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/lexicon-pharmaceuticals-global-inpefa-expansion-and-late-stage-pipeline-catalysts-support-buy-rating-and-4-target-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/lexicon-pharmaceuticals-global-inpefa-expansion-and-late-stage-pipeline-catalysts-support-buy-rating-and-4-target-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SSI","LXRX"],"gpt_icon":0},{"id":"2604111216","title":"Vizsla Silver Fully Funds Panuco as Project Moves From Study Stage to Construction Readiness","url":"https://stock-news.laohu8.com/highlight/detail?id=2604111216","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604111216?lang=en_us&edition=fundamental","pubTime":"2026-01-20 22:31","pubTimestamp":1768919464,"startTime":"0","endTime":"0","summary":"An update from Vizsla Silver ( ($TSE:VZLA) ) is now available. Vizsla Silver’s 2025 year-end update underscores a major transition from study and e...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vizsla-silver-fully-funds-panuco-as-project-moves-from-study-stage-to-construction-readiness?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vizsla-silver-fully-funds-panuco-as-project-moves-from-study-stage-to-construction-readiness?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SImain","SSI"],"gpt_icon":0},{"id":"2604911557","title":"Definium Therapeutics: Advancing Late-Stage Psychedelic Pipeline and Diversifying Assets Underpin Buy Rating and $61 Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2604911557","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604911557?lang=en_us&edition=fundamental","pubTime":"2026-01-20 21:06","pubTimestamp":1768914414,"startTime":"0","endTime":"0","summary":"Justin Walsh, an analyst from JonesTrading, reiterated the Buy rating on Definium Therapeutics. The associated price target remains the same with $...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/definium-therapeutics-advancing-late-stage-psychedelic-pipeline-and-diversifying-assets-underpin-buy-rating-and-61-target-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/definium-therapeutics-advancing-late-stage-psychedelic-pipeline-and-diversifying-assets-underpin-buy-rating-and-61-target-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SSI","DFTX"],"gpt_icon":0},{"id":"2604113568","title":"Invivyd to Launch Mid-Stage Trial for Investigational Antibody on Long COVID","url":"https://stock-news.laohu8.com/highlight/detail?id=2604113568","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604113568?lang=en_us&edition=fundamental","pubTime":"2026-01-20 20:58","pubTimestamp":1768913900,"startTime":"0","endTime":"0","summary":"Invivyd  said Tuesday that it plans to launch a mid-stage clinical trial, along with the SPEAR Study Group, that assesses the safety, translational biology, and exploratory clinical efficacy of investigational antibody VYD2311 in individuals with Long COVID or COVID vaccine injury.The trial will evaluate multiple high doses of the antibody across many months of therapy, the company said.The mid-stage trial is expected to begin by mid-2026, with further details to be announced in the coming months, Invivyd said.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IVVD","BK4539","BK4139","SSI"],"gpt_icon":0},{"id":"2604719734","title":"Reaffirming Axsome Therapeutics as a Buy on Robust Commercial Growth and Advancing Late‑Stage Pipeline, With a Raised $260 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2604719734","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604719734?lang=en_us&edition=fundamental","pubTime":"2026-01-20 19:37","pubTimestamp":1768909031,"startTime":"0","endTime":"0","summary":"Ram Selvaraju, an analyst from H.C. Wainwright, reiterated the Buy rating on Axsome Therapeutics. The associated price target was raised to $260.00...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/reaffirming-axsome-therapeutics-as-a-buy-on-robust-commercial-growth-and-advancing-late‑stage-pipeline-with-a-raised-260-price-target-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/reaffirming-axsome-therapeutics-as-a-buy-on-robust-commercial-growth-and-advancing-late‑stage-pipeline-with-a-raised-260-price-target-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SSI","AXSM"],"gpt_icon":0},{"id":"2604318224","title":"Amigo Launches Early-Stage Gold Exploration Push in Tanzania","url":"https://stock-news.laohu8.com/highlight/detail?id=2604318224","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604318224?lang=en_us&edition=fundamental","pubTime":"2026-01-19 17:57","pubTimestamp":1768816669,"startTime":"0","endTime":"0","summary":"Amigo Holdings PLC ( ($GB:AMGO) ) has shared an announcement. Amigo Holdings PLC has provided a corporate update on its strategic pivot toward gold...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/amigo-launches-early-stage-gold-exploration-push-in-tanzania?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/amigo-launches-early-stage-gold-exploration-push-in-tanzania?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["UGL","1OZmain","BK4535","BK4588","SSI","GDX","BK4504","BK4585","IAU"],"gpt_icon":0},{"id":"2604922008","title":"'Approval Is Not Possible At This Stage,' EPP Chief Says, Threatening Collapse Of EU-US Trade Deal: 'Must Be Put On Hold'","url":"https://stock-news.laohu8.com/highlight/detail?id=2604922008","media":"Benzinga_recent_news","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604922008?lang=en_us&edition=fundamental","pubTime":"2026-01-18 13:06","pubTimestamp":1768712760,"startTime":"0","endTime":"0","summary":"EU lawmakers to halt approval of EU-US trade deal after Trump threatens tariffs on countries backing Greenland in dispute with Washington.","market":"sh","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/01/18/Washington--February-22--2025-President-.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/01/18/Washington--February-22--2025-President-.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/news/politics/26/01/49984678/approval-is-not-possible-at-this-stage-epp-chief-says-threatening-collapse-of-eu-us-trade-deal-must-be-put-on-hold","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/politics/26/01/49984678/approval-is-not-possible-at-this-stage-epp-chief-says-threatening-collapse-of-eu-us-trade-deal-must-be-put-on-hold","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["SSI","BK4582","BK4156","EPP"],"gpt_icon":0},{"id":"2604427369","title":"Health In Tech: Early-Stage Disruptor Poised for High-Growth Expansion, Underpinned by Strong Balance Sheet and Strategic Partnerships","url":"https://stock-news.laohu8.com/highlight/detail?id=2604427369","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604427369?lang=en_us&edition=fundamental","pubTime":"2026-01-17 20:45","pubTimestamp":1768653944,"startTime":"0","endTime":"0","summary":"Health In Tech, Inc. Class A, the Technology sector company, was revisited by a Wall Street analyst yesterday. Analyst Allen Klee from Maxim Group ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/health-in-tech-early-stage-disruptor-poised-for-high-growth-expansion-underpinned-by-strong-balance-sheet-and-strategic-partnerships-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/health-in-tech-early-stage-disruptor-poised-for-high-growth-expansion-underpinned-by-strong-balance-sheet-and-strategic-partnerships-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SSI"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":10,"totalSize":200,"code":"91000000","status":"200"}]}}